A review of non-invasive insulin delivery systems for diabetes therapy in clinical trials over the past decade.

Clinical Trials as Topic Diabetes Mellitus / drug therapy Drug Delivery Systems Humans Hypoglycemic Agents / administration & dosage Insulin / administration & dosage

Journal

Drug discovery today
ISSN: 1878-5832
Titre abrégé: Drug Discov Today
Pays: England
ID NLM: 9604391

Informations de publication

Date de publication:
02 2019
Historique:
received: 14 09 2018
revised: 19 10 2018
accepted: 15 11 2018
pubmed: 23 11 2018
medline: 1 8 2019
entrez: 23 11 2018
Statut: ppublish

Résumé

At present, the main form of insulin administration is the invasive subcutaneous (s.c.) route and, for many patients, this means managing their glucose levels with multiple daily injections, which is both painful and difficult to administer chronically. To increase patient compliance, products are slowly reaching the market that are more patient friendly, such as the insulin patch-pump systems, including Omnipod and V-Go, but also the inhaled-insulin Afrezza

Identifiants

DOI: 10.1016/j.drudis.2018.11.010 PMID: 30465877
pubmed: 30465877
pii: S1359-6446(18)30254-X
doi: 10.1016/j.drudis.2018.11.010
pii:
doi:

Substances chimiques

Hypoglycemic Agents 0
Insulin 0

Types de publication

Journal Article Review

Langues

eng

Pagination

440-451

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Najma Easa (N)

School of Life Sciences, Pharmacy & Chemistry, Kingston University, London, KT1 2EE, UK.

Raid G Alany (RG)

School of Life Sciences, Pharmacy & Chemistry, Kingston University, London, KT1 2EE, UK.

Mark Carew (M)

School of Life Sciences, Pharmacy & Chemistry, Kingston University, London, KT1 2EE, UK.

Anil Vangala (A)

School of Life Sciences, Pharmacy & Chemistry, Kingston University, London, KT1 2EE, UK. Electronic address: a.vangala@kingston.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études cliniques comme sujet › Essais cliniques comme sujet › A review of non-invasive insulin delivery...
questionsmedicales.fr › Maladies endocriniennes › Diabète › A review of non-invasive insulin delivery...
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Systèmes de délivrance de médicaments › A review of non-invasive insulin delivery...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › A review of non-invasive insulin delivery...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Hypoglycémiants › A review of non-invasive insulin delivery...
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Hormones peptidiques › Hormones pancréatiques › Insulines › Insuline › A review of non-invasive insulin delivery...